Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UK BROKER RATINGS SUMMARY: Berenberg Downgrades Ashmore And Man Group

Mon, 22nd Jun 2020 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

GOLDMAN SACHS RAISES BUNZL PRICE TARGET TO 2500 (2350) PENCE - 'BUY'

----------

SOCGEN RAISES KINGFISHER PRICE TARGET TO 222 (174) PENCE - 'HOLD'

----------

ODDO BHF RAISES GLAXOSMITHKLINE PRICE TARGET TO 1840 (1760) PENCE - 'NEUTRAL'

----------

ODDO BHF CUTS ASTRAZENECA TO 'REDUCE' ('BUY') - PRICE TARGET 7600 (8100) PENCE

----------

MORGAN STANLEY RAISES PRUDENTIAL PRICE TARGET TO 1626 (1619) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES JOHNSON MATTHEY TARGET TO 2850 (2700) P - 'OVERWEIGHT'

----------

BARCLAYS RAISES SEGRO PRICE TARGET TO 950 (900) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES ASHTEAD GROUP TARGET TO 3390 (2500) PENCE - 'OUTPERFORM'

----------

JPMORGAN RAISES ASHTEAD GROUP PRICE TARGET TO 2900 (2700) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES CRH PRICE TARGET TO 33.70 (33) EUR - 'BUY'

----------

JEFFERIES RAISES BARCLAYS PRICE TARGET TO 212 (206) PENCE - 'BUY'

---------

FTSE 250

----------

MORGAN STANLEY RAISES JOHN WOOD PRICE TARGET TO 270 (250) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES JOHN WOOD PRICE TARGET TO 300 (230) PENCE - 'BUY'

----------

BARCLAYS RAISES TRITAX BIG BOX PRICE TARGET TO 140 (125) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS RAISES LONDONMETRIC PROPERTY TARGET TO 235 (210) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS CARNIVAL PRICE TARGET TO 1310 (4040) PENCE - 'EQUAL WEIGHT'

----------

BERENBERG RAISES JUPITER FUND PRICE TARGET TO 196 (169) PENCE - 'SELL'

----------

BERENBERG CUTS MAN GROUP TO 'HOLD' ('BUY') - TARGET 148 (160) PENCE

----------

BERENBERG CUTS ASHMORE GROUP TO 'SELL' ('HOLD') - TARGET 331 PENCE

----------

CREDIT SUISSE CUTS AGGREKO TO 'UNDERPERFORM' ('OUTPERFORM') - TARGET 295 (575) PENCE

----------

RBC CUTS WORKSPACE GROUP PRICE TARGET TO 775 (875) PENCE - 'SECTOR PERFORM'

----------

GOLDMAN SACHS CUTS BODYCOTE TO 'SELL' ('NEUTRAL') - TARGET 520 (510) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG CUTS JOHN MENZIES PRICE TARGET TO 210 (540) PENCE - 'BUY'

----------

GOLDMAN RAISES HUNTING TO 'BUY' ('SELL') - TARGET 340 (180) PENCE

----------

JEFFERIES RAISES BURFORD CAPITAL PRICE TARGET TO 950 (800) PENCE - 'BUY'

----------

RBC RAISES FEVERTREE DRINKS TO 'OUTPERFORM' ('SECTOR PERFORM') TARGET 2500 (1100) PENCE

----------

JPMORGAN RAISES ASOS PRICE TARGET TO 3900 (3500) PENCE - 'OVERWEIGHT'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.